Suzuken Co Ltd
TSE:9987
EV/OCF
Enterprise Value to OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.
Market Cap | EV/OCF | ||||
---|---|---|---|---|---|
JP |
Suzuken Co Ltd
TSE:9987
|
353.3B JPY | 1.2 | ||
US |
Mckesson Corp
NYSE:MCK
|
70.1B USD | 21.2 | ||
US |
Cencora Inc
NYSE:COR
|
47.5B USD | 11.9 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 11.7 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
25.3B USD | 6.1 | ||
US |
Henry Schein Inc
NASDAQ:HSIC
|
9.5B USD | 23 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | -316.6 | |
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
67.9B HKD | 3.9 | ||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
57.3B CNY | 17.2 | ||
IT |
Amplifon SpA
MIL:AMP
|
7.1B EUR | 19.3 | ||
CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
50.7B CNY | 13.6 |
EV/OCF Forward Multiples
Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.